ExamWorks Group Given New $39.00 Price Target at Needham & Company (EXAM)
Research analysts at Needham & Company boosted their price target on shares of ExamWorks Group (NASDAQ:EXAM) from $33.00 to $39.00 in a report released on Wednesday, American Banking and Market News reports. Needham & Company’s price objective would suggest a potential upside of 27.45% from the stock’s previous close.
A number of other analysts have also recently weighed in on EXAM. Analysts at Credit Suisse raised their price target on shares of ExamWorks Group from $32.00 to $37.00 in a research note on Wednesday. Analysts at Zacks downgraded shares of ExamWorks Group from an “outperform” rating to a “neutral” rating in a research note on Tuesday, December 3rd. They now have a $31.90 price target on the stock.
ExamWorks Group (NASDAQ:EXAM) traded up 17.19% during mid-day trading on Wednesday, hitting $35.86. 2,513,612 shares of the company’s stock traded hands. ExamWorks Group has a 52-week low of $13.82 and a 52-week high of $32.48. The stock has a 50-day moving average of $30.55 and a 200-day moving average of $27.52. The company’s market cap is $1.306 billion.
ExamWorks Group (NASDAQ:EXAM) last issued its quarterly earnings data on Tuesday, February 25th. The company reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.06) by $0.02. The company had revenue of $158.80 million for the quarter, compared to the consensus estimate of $151.51 million. On average, analysts predict that ExamWorks Group will post $0.08 earnings per share for the current fiscal year.
ExamWorks Group, Inc (NASDAQ:EXAM) is a provider of independent medical examinations (IMEs), peer and bill reviews, and related services, referred to as IME services or the IME industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.